Creative Medical Technology Holdings Inc (CELZ)

Finanzdaten der Creative Medical Technology Holdings Inc-Aktie (CELZ)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	0.003	0.006	-	-
Cost Of Revenue	100.00% -	0.0012	0.0024	-	-
Gross Profit	100.00% -	0.0018	0.0036	-	-
Operating Expenses	36.68% 1.1231	1.7736	1.5468	1.192	1.1131
Interest Income/Expense	-	-	-	-	0.000050
Depreciation and Amortization	0.046	-	-	-	-
Operating Income/Loss	36.61% -1.1231	-1.7718	-1.5432	-1.192	-1.1131
Nonoperating Income/Loss	12.50% 0.0816	0.0933	0.0892	0.0899	0.0611
Income/Loss From Continuing Operations Before Tax	37.95% -1.0415	-1.6786	-1.454	-1.1021	-1.0519
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	37.95% -1.0415	-1.6786	-1.454	-1.1021	-1.0519
Net Income/Loss	37.95% -1.0415	-1.6786	-1.454	-1.1021	1.0519
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	2.1038
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-